Paclitaxel


ATC CODE

  • L01CD01

INDICATIONS AND NEMLC RECOMMENDATIONS

INDICATIONS AND NEMLC RECOMMENDATIONS 1

INDICATION

  • Neoadjuvant/recurrent/ metastatic head and neck cancer.

NEMLC RECOMMENDATION

  • Not Approved

REVIEW INDICATORS

  • n/a

DATE RATIFIED

  • 27 July 2014



INDICATIONS AND NEMLC RECOMMENDATIONS 2

INDICATION

  • First-line chemotherapy in advanced non-small cell lung cancer (NSCLC) .

NEMLC RECOMMENDATION

  • Approved

REVIEW INDICATORS

  • None

DATE RATIFIED

  • 22 January 2015



INDICATIONS AND NEMLC RECOMMENDATIONS 3

INDICATION

  • Metastatic cervical carcinoma.

NEMLC RECOMMENDATION

  • Approved

REVIEW INDICATORS

  • None

DATE RATIFIED

  • 11 July 2019